Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06202976

Mapping Epileptic Networks Using Multimodal Imaging

Status
Recruiting
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Imagine Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations. To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI). It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery. The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.

Conditions

Interventions

TypeNameDescription
OTHERSecondary data collectionclinical data

Timeline

Start date
2017-09-14
Primary completion
2033-09-13
Completion
2033-09-13
First posted
2024-01-12
Last updated
2025-04-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06202976. Inclusion in this directory is not an endorsement.

Mapping Epileptic Networks Using Multimodal Imaging (NCT06202976) · Clinical Trials Directory